sulfinpyrazone has been researched along with Cryoglobulinemia in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Cryoglobulinemia: A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Platelet production time (PPT), circulating platelet aggregates (CPA ratio) and plasma beta-thromboglobulin (beta TG) were determined in patients with essential mixed cryoglobulinemia (EMC) before and after two months' treatment with sulfinpyrazone." | 7.67 | Treatment with sulfinpyrazone of essential mixed cryoglobulinemia. ( Boschetti, C; Cortellaro, M; Invernizzi, F; Massaro, P; Polli, E; Rigolone, A, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boschetti, C | 1 |
| Cortellaro, M | 1 |
| Invernizzi, F | 1 |
| Massaro, P | 1 |
| Rigolone, A | 1 |
| Polli, E | 1 |
1 other study available for sulfinpyrazone and Cryoglobulinemia
| Article | Year |
|---|---|
Treatment with sulfinpyrazone of essential mixed cryoglobulinemia.
Topics: Adult; Aged; beta-Thromboglobulin; Blood Platelets; Cryoglobulinemia; Female; Humans; Male; Middle A | 1985 |